Search

everythinglearnresearchcommunity

for

Search:↓

HPT axis hormones boost mitochondrial function and growth in hair follicles, potentially aiding hair health.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

MTS effectively improves hair density and thickness in menopausal women with hair loss.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.

Including androgens in hormone therapy may lower breast cancer risk.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

The method can measure multiple hormones in women's hair and may help identify hormone-related health issues.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Sex steroids affect the MafB gene differently in male and female hamsters.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Tribulus terrestris extract significantly increases MSH expression and melanin production in mouse hair follicles.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.